LTZ Therapeutics Secures $17 Million Pre-Series A Financing for Immunotherapy Development to Treat Cancer & Other Complex Diseases
/PRNewswire/ -- LTZ Therapeutics – an immunotherapy-focused biotech company, co-founded by seasoned drug developers Robert Li Ph.D, Martin Treder Ph.D and...
Source: prnewswire.com